Skip to main content
Equibles

JANE STREET GROUP, LLC

Position in VKTX — Viking Therapeutics, Inc.

CIK 1595888 NEW YORK, NY
Back to VKTX Full portfolio

Position in VKTX

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$24,370,799
-$28,438,495 QoQ
Shares Held
748,949
-50.1% QoQ
Ownership
0.645%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VKTX Over Time

Shares Held

Position Value (USD)

Derivatives in VKTX

reported options exposure · as of Mar 31, 2026
CallValue
$8,203,334
CallShares
252,100
PutValue
$6,218,394
PutShares
191,100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

JANE STREET GROUP, LLC holds $1,255,284,514 across 317 Biotechnology names. VKTX ranks #13 (1.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BBIO
BridgeBio Pharma, Inc.
 1,757,672 $130,524,721
2 RPRX
Royalty Pharma plc
 2,400,382 $115,146,324
3 TGTX
Tg Therapeutics, Inc.
 2,041,669 $67,824,242
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 122,946 $54,900,305
5 HALO
Halozyme Therapeutics, Inc.
 831,707 $53,753,223
6 EXEL
Exelixis, Inc.
 1,087,030 $46,622,715
7 JAZZ
Jazz Pharmaceuticals plc
 223,615 $42,274,415
8 BNTX
BioNTech SE
 336,757 $29,930,962

All Filings in VKTX

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $24,370,799 748,949
2026-03-31 $6,218,394 191,100
2026-03-31 $8,203,334 252,100
2025-12-31 $22,374,480 636,000
2025-12-31 $8,675,388 246,600
2025-12-31 $52,809,294 1,501,117
2025-09-30 $7,763,112 295,400
2025-09-30 $18,540,540 705,500
2025-09-30 $20,861,220 793,806
2025-06-30 $13,416,950 506,300
2025-06-30 $2,480,400 93,600
2025-06-30 $19,402,610 732,174
2025-03-31 $4,507,500 186,646
2025-03-31 $3,673,215 152,100
2025-03-31 $17,465,280 723,200
2024-12-31 $16,405,002 407,679
2024-12-31 $11,339,632 281,800
2024-12-31 $23,890,488 593,700
2024-09-30 $21,449,870 338,807
2024-09-30 $30,312,828 478,800
2024-09-30 $21,449,428 338,800
2024-06-30 $20,320,429 383,332
2024-03-31 $28,461,216 347,088
2023-12-31 $6,517,965 350,240
2023-09-30 $2,800,697 252,999
2023-06-30 $8,786,954 542,070
2023-03-31 $5,954,789 357,645
2022-12-31 $543,460 57,815
2022-09-30 $35,106 12,907
2022-06-30 $82,771 28,641
2022-03-31 $122,574 40,858
2021-12-31 $217,120 47,200
2021-12-31 $104,111 22,633
2021-09-30 $530,032 84,400
2021-09-30 $191,772 30,537
2021-06-30 $127,587 21,300
2021-06-30 $628,950 105,000
2021-03-31 $722,947 114,300
2021-03-31 $467,676 73,941
2021-03-31 $273,872 43,300
2020-12-31 $94,584 16,800
2020-12-31 $422,813 75,100
2020-12-31 $179,923 31,958
2020-09-30 $94,284 16,200
2020-09-30 $943,422 162,100
2020-09-30 $206,557 35,491
2020-06-30 $86,433 11,988
2020-06-30 $2,378,579 329,900
2020-06-30 $126,175 17,500
2020-03-31 $65,309 13,955

Report a Problem

Category
Description
Email (optional, for follow-up)